Pyronaridine‐artesunate (PY‐AS) vs mefloquine plus artesunate (MQ + AS)
Total failure: day 28 (PCR‐adjusted) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in total failure: day 28 (PCR‐adjusted) compared with mefloquine plus artesunate (MQ + AS) (low certainty).
1 finding from 1 review
- Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria 2022 · Cochrane Headline outcomes onlyRR 0.37 [0.13, 1.05]1 study · 1117 participantsLow